Correlation Between Bristol-Myers Squibb and PT Indocement

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and PT Indocement at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and PT Indocement into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and PT Indocement Tunggal, you can compare the effects of market volatilities on Bristol-Myers Squibb and PT Indocement and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of PT Indocement. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and PT Indocement.

Diversification Opportunities for Bristol-Myers Squibb and PT Indocement

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and PITPF is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and PT Indocement Tunggal in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PT Indocement Tunggal and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with PT Indocement. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PT Indocement Tunggal has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and PT Indocement go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and PT Indocement

If you would invest (100.00) in PT Indocement Tunggal on December 1, 2024 and sell it today you would earn a total of  100.00  from holding PT Indocement Tunggal or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  PT Indocement Tunggal

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest fragile performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
PT Indocement Tunggal 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PT Indocement Tunggal has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, PT Indocement is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Bristol-Myers Squibb and PT Indocement Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and PT Indocement

The main advantage of trading using opposite Bristol-Myers Squibb and PT Indocement positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, PT Indocement can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PT Indocement will offset losses from the drop in PT Indocement's long position.
The idea behind Bristol Myers Squibb and PT Indocement Tunggal pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world